C

Bio-Rad Laboratories, Inc. BIOB

NYSE
Recommendation
Dividend Power Score
Day's Range
$379.50$379.50
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
My Lists My Alerts
Access our Premium Ratings
Get Access

BIOB Rating

Reward
Risk

BIOB Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

BIOB Company Overview

Bio-Rad Laboratories, Inc. is a U.S.-based life science and clinical diagnostics company that develops, manufactures, and distributes a broad range of products used in biological research, healthcare diagnostics, and biopharmaceutical production. The company operates primarily in the biotechnology, medical diagnostics, and laboratory instrumentation industries, serving academic institutions, hospitals, pharmaceutical companies, biotechnology firms, and industrial laboratories. Its principal revenue drivers include reagents, instruments, software, consumables, and quality control products used in molecular biology, immunology, cell biology, gene expression analysis, and clinical laboratory testing.

The company’s operations are organized primarily around its Life Science and Clinical Diagnostics business segments. Bio-Rad has built a strong market position through its portfolio of proprietary technologies, recurring consumables revenue, and long-standing customer relationships in regulated laboratory environments. Founded in 1952 by David and Alice Schwartz in California, the company initially focused on specialty chemicals for research applications before expanding into analytical instruments, diagnostic testing systems, and digital biology technologies through internal development and acquisitions. Bio-Rad has also maintained a significant equity investment in Sartorius AG, which has contributed materially to its balance sheet value and investment profile in recent years.

Data compiled by narrative technology. May contain errors.
Sector

BIOB Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

BIOB Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

BIOB Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

BIOB Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

BIOB Valuation

Market Cap
Market Cap Rank
#2,431
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

BIOB Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

BIOB Corporate Info

Phone Number
510 724 7000
Address
1000 Alfred Nobel Drive
Hercules, CA 94547
Country
Year Founded

BIOB Filings

Filing Date
Wednesday, November 4, 2026
Period Date
Wednesday, September 30, 2026
Next Filing
Week of Feb 8 and 12 (est)

BIOB Headlines

There are no news to display.